$TOMZ
TOMI Environmental Solutions, Inc. Stock $tomz

$tomz Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000165495424009807 Filed on August 01, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q2
Revenue	$2.542M	$3.013M	$2.775M
YoY Change	72.94%	8.6%	90.26%
Cost Of Revenue	$981.1K	$1.159M	$1.074M
YoY Change	48.41%	7.86%	100.04%
Gross Profit	$1.561M	$1.855M	$1.700M
YoY Change	92.99%	9.07%	84.55%
Gross Profit Margin	61.41%	61.54%	61.28%
Selling, General & Admin	$1.241M	$1.571M	$1.444M
YoY Change	-3.59%	8.8%	-7.55%
% of Gross Profit	79.52%	84.74%	84.95%
Research & Development	$56.34K	$61.61K	$73.73K
YoY Change	-26.2%	-16.43%	-25.79%
% of Gross Profit	3.61%	3.32%	4.34%
Depreciation & Amortization	$65.03K	$71.68K	$86.77K
YoY Change	-27.87%	-17.39%	9.66%
% of Gross Profit	4.17%	3.86%	5.1%
Operating Expenses	$1.412M	$1.733M	$1.789M
YoY Change	-17.42%	-3.16%	0.29%
Operating Profit	$149.1K	$121.8K	-$88.94K
YoY Change	-116.55%	-236.96%	-89.69%
Interest Expense	$93.62K	$93.46K	$350.00
YoY Change	35907.69%	26602.57%
% of Operating Profit	62.79%	76.72%
Other Income/Expense, Net	-$90.14K	-$91.61K	$349.00
YoY Change	-35310.94%	-26350.43%	4.18%
Pretax Income	$58.96K	$30.20K	-$88.59K
YoY Change	-106.55%	-134.09%	-89.73%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income	0.0%	0.0%
Net Earnings	$58.96K	$30.20K	-$88.59K
YoY Change	-106.55%	-134.09%	-89.73%
Net Earnings / Revenue	2.32%	1.0%	-3.19%
Basic Earnings Per Share	$0.00	$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	20.02M shares	19.96M shares	19.82M shares
Diluted Shares Outstanding	20.10M shares	22.13M shares	19.82M shares

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$809.0K	$709.1K	$1.574M
YoY Change	-42.65%	-54.95%	-67.21%
Cash & Equivalents	$809.0K	$709.1K	$1.574M
Short-Term Investments
Other Short-Term Assets	$443.3K	$416.4K	$494.7K
YoY Change	-16.69%	-15.83%	-26.47%
Inventory	$4.580M	$4.282M	$4.413M
Prepaid Expenses	$345.8K	$290.2K	$291.2K
Receivables	$3.146M	$3.664M	$3.379M
Other Receivables	$164.2K	$164.2K	$164.2K
Total Short-Term Assets	$9.143M	$9.235M	$10.02M
YoY Change	2.08%	-7.88%	-18.88%
LONG-TERM ASSETS
Property, Plant & Equipment	$914.2K	$983.6K	$1.238M
YoY Change	-19.69%	-20.56%	-9.1%
Goodwill
YoY Change
Intangibles	$1.939M	$1.944M	$1.819M
YoY Change	6.86%	6.91%	3.3%
Long-Term Investments
YoY Change
Other Assets	$672.6K	$638.4K	$565.5K
YoY Change	12.82%	12.88%	36.86%
Total Long-Term Assets	$3.319M	$3.376M	$3.321M
YoY Change	2.66%	1.66%	0.29%
TOTAL ASSETS
Total Short-Term Assets	$9.143M	$9.235M	$10.02M
Total Long-Term Assets	$3.319M	$3.376M	$3.321M
Total Assets	$12.46M	$12.61M	$13.35M
YoY Change	2.23%	-5.51%	-14.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.552M	$1.714M	$1.360M
YoY Change	24.28%	26.02%	35.66%
Accrued Expenses	$663.2K	$635.1K	$755.5K
YoY Change	-15.71%	-15.93%	-8.27%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.215M	$2.407M	$2.262M
YoY Change	8.82%	6.39%	-7.03%
LONG-TERM LIABILITIES
Long-Term Debt	$2.345M	$2.329M	$0.00
YoY Change
Other Long-Term Liabilities	$546.8K	$579.7K	$702.0K
YoY Change	-18.69%	-17.42%	-13.47%
Total Long-Term Liabilities	$2.892M	$2.909M	$702.0K
YoY Change	329.99%	314.4%	-13.47%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.215M	$2.407M	$2.262M
Total Long-Term Liabilities	$2.892M	$2.909M	$702.0K
Total Liabilities	$5.107M	$5.316M	$2.964M
YoY Change	88.57%	79.33%	-8.64%
SHAREHOLDERS EQUITY
Retained Earnings	-$51.05M	-$51.11M	-$47.70M
YoY Change	5.03%	7.14%	5.85%
Common Stock	$200.2K	$200.2K	$198.2K
YoY Change	0.96%	0.96%	0.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$7.355M	$7.296M	$10.38M
YoY Change
Total Liabilities & Shareholders Equity	$12.46M	$12.61M	$13.35M
YoY Change	2.23%	-5.51%	-14.83%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2023 Q2
OPERATING ACTIVITIES
Net Income	$58.96K	$30.20K	-$88.59K
YoY Change	-106.55%	-134.09%	-89.73%
Depreciation, Depletion And Amortization	$65.03K	$71.68K	$86.77K
YoY Change	-27.87%	-17.39%	9.66%
Cash From Operating Activities	$105.3K	-$379.7K	-$835.0K
YoY Change	-165.11%	-54.53%	74.59%
INVESTING ACTIVITIES
Capital Expenditures	$5.380K	$4.440K	$60.21K
YoY Change	25.12%	-92.63%	-216.24%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$5.380K	-$4.440K	-$60.21K
YoY Change	25.12%	-92.63%	16.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	0.000
YoY Change
NET CHANGE
Cash From Operating Activities	105.3K	-379.7K	-835.0K
Cash From Investing Activities	-5.380K	-4.440K	-60.21K
Cash From Financing Activities	0.000	0.000
Net Change In Cash	99.93K	-384.1K	-895.2K
YoY Change	-160.18%	-57.09%	68.89%
FREE CASH FLOW
Cash From Operating Activities	$105.3K	-$379.7K	-$835.0K
Capital Expenditures	$5.380K	$4.440K	$60.21K
Free Cash Flow	$99.93K	-$384.1K	-$895.2K
YoY Change	-160.18%	-57.09%	109.92%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0000314227
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19923955	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20015205	shares
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	30000	usd
	tomz	Amortization Of Tenant Improvement Allowance AmortizationOfTenantImprovementAllowance	19597	usd
CY2023Q2	tomz	Amortization Of Tenant Improvement Allowance AmortizationOfTenantImprovementAllowance	9798	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	3766	usd
	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	7531	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-09908
	dei	Entity Registrant Name EntityRegistrantName	TOMI ENVIRONMENTAL SOLUTIONS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	59-1947988
	dei	Entity Address Address Line1 EntityAddressAddressLine1	8430 Spires Way
	dei	Entity Address City Or Town EntityAddressCityOrTown	Frederick
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	21701
	dei	City Area Code CityAreaCode	800
	dei	Local Phone Number LocalPhoneNumber	525-1698
	dei	Security12b Title Security12bTitle	Common stock, par value $0.01 per share
	dei	Trading Symbol TradingSymbol	TOMZ
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20015205	shares
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	709110	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2339059	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3663862	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2429929	usd
CY2024Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	164150	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	164150	usd
CY2024Q2	tomz	Inventory Current InventoryCurrent	4281614	usd
CY2023Q4	tomz	Inventory Current InventoryCurrent	4627103	usd
CY2024Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	126185	usd
CY2023Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	29335	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	290195	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	371298	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	9235116	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	9960874	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	983601	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1048642	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1113491	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1123246	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	434607	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	467935	usd
CY2024Q2	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	206240	usd
CY2023Q4	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	206240	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	638392	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	550677	usd
CY2024Q2	us-gaap	Other Assets OtherAssets	2392730	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	2348098	usd
CY2024Q2	us-gaap	Assets Assets	12611447	usd
CY2023Q4	us-gaap	Assets Assets	13357614	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1714489	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1267029	usd
CY2024Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	512829	usd
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	675491	usd
CY2024Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	57192	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	0	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	122259	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	115658	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2406769	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2058178	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	579715	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	642527	usd
CY2024Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	2329254	usd
CY2023Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	2298015	usd
CY2024Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2908969	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2940542	usd
CY2024Q2	us-gaap	Liabilities Liabilities	5315738	usd
CY2023Q4	us-gaap	Liabilities Liabilities	4998720	usd
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19923955	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	200152	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	199240	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	58201140	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	57985245	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-51106221	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-49826229	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	7295709	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	8358894	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12611447	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13357614	usd
CY2024Q2	us-gaap	Revenues Revenues	3013392	usd
CY2023Q2	us-gaap	Revenues Revenues	2774699	usd
	us-gaap	Revenues Revenues	4127479	usd
	us-gaap	Revenues Revenues	4356871	usd
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue	1158876	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	1074420	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1602295	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1715355	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	1854516	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	1700279	usd
	us-gaap	Gross Profit GrossProfit	2525184	usd
	us-gaap	Gross Profit GrossProfit	2641516	usd
CY2024Q2	us-gaap	Professional Fees ProfessionalFees	84327	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	111660	usd
	us-gaap	Professional Fees ProfessionalFees	282326	usd
	us-gaap	Professional Fees ProfessionalFees	248845	usd
CY2024Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	76554	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	90560	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	154475	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	179336	usd
CY2024Q2	us-gaap	Selling Expense SellingExpense	366265	usd
CY2023Q2	us-gaap	Selling Expense SellingExpense	501045	usd
	us-gaap	Selling Expense SellingExpense	655334	usd
	us-gaap	Selling Expense SellingExpense	877698	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	61614	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	73728	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	129585	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	144248	usd
CY2024Q2	us-gaap	Legal Fees LegalFees	23095	usd
CY2023Q2	us-gaap	Legal Fees LegalFees	68912	usd
	us-gaap	Legal Fees LegalFees	136730	usd
	us-gaap	Legal Fees LegalFees	144367	usd
CY2024Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1120849	usd
CY2023Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	943314	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	2271398	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	2324108	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	1732704	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	1789219	usd
	us-gaap	Operating Expenses OperatingExpenses	3629848	usd
	us-gaap	Operating Expenses OperatingExpenses	3918602	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	121812	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-88940	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1104664	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1277086	usd
CY2024Q2	us-gaap	Interest Income Other InterestIncomeOther	1845	usd
CY2023Q2	us-gaap	Interest Income Other InterestIncomeOther	349	usd
	us-gaap	Interest Income Other InterestIncomeOther	11751	usd
	us-gaap	Interest Income Other InterestIncomeOther	1008	usd
CY2024Q2	us-gaap	Interest Expense InterestExpense	93459	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	0	usd
	us-gaap	Interest Expense InterestExpense	187079	usd
	us-gaap	Interest Expense InterestExpense	0	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-91614	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	349	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-175328	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1008	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	30198	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-88591	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1279992	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1276078	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	30198	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-88591	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1279992	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1276078	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19984875	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19823955	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19968495	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19815336	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22133562	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19823955	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19968495	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19815336	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	8358894	usd
	tomz	Warrants And Options Exercised Amount WarrantsAndOptionsExercisedAmount	27500	usd
	tomz	Common Stock Issued For Services Provided Amount CommonStockIssuedForServicesProvidedAmount	45000	usd
	tomz	Equity Compensation EquityCompensation	144307	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1279992	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	7295709	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11448200	usd
	tomz	Equity Compensation EquityCompensation	158833	usd
	tomz	Common Stock Issued For Services Provided Amount CommonStockIssuedForServicesProvidedAmount	51000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1276078	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	10381955	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	7076204	usd
CY2024Q2	tomz	Equity Compensation EquityCompensation	144307	usd
CY2024Q2	tomz	Common Stock Issued For Services Provided Amount CommonStockIssuedForServicesProvidedAmount	45000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	30198	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	7295709	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	10470546	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-88591	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	10381955	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1279992	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1276078	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	154475	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	179336	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	78657	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	78657	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	31240	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	usd
	tomz	Equity Compensation Expense EquityCompensationExpense	144307	usd
	tomz	Equity Compensation Expense EquityCompensationExpense	158833	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	45000	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	51000	usd
	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	223371	usd
	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	125000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1010563	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	481810	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-345489	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-83213	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-81103	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-97135	usd
	tomz	Increase Decrease In Vendor Deposits IncreaseDecreaseInVendorDeposits	96850	usd
	tomz	Increase Decrease In Vendor Deposits IncreaseDecreaseInVendorDeposits	-243593	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	87715	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	90437	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	406145	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-401312	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-121347	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-82573	usd
	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	57192	usd
	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	-553351	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-81943	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-79556	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1558173	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2198350	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	99276	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	94295	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-99276	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-94295	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	27500	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	27500	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1629949	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2292645	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2339059	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3866733	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	709110	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1574088	usd
	us-gaap	Interest Paid Net InterestPaidNet	148500	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 1. DESCRIPTION OF BUSINESS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">TOMI Environmental Solutions, Inc., a Florida corporation (“TOMI”, the “Company”, “we”, “our” and “us”) is a global provider of disinfection and decontamination essentials through our premier Binary Ionization Technology® (BIT™) platform, under which we manufacture, license, service and sell our SteraMist® brand of products, including SteraMist® BIT™, a hydrogen peroxide-based mist and fog. Our solution and process are environmentally friendly as the only biproduct from our decontamination process is oxygen and water in the form of humidity. Our solution is organically listed in the United States and Canada as a sustainably green product with no or very little carbon footprint. Our business is organized into five divisions: Life Sciences, Healthcare, TOMI Service Network, Food Safety and Commercial.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Invented under a defense grant in association with the Defense Advanced Research Projects Agency (“DARPA”) of the U.S. Department of Defense, BIT™ is registered with the U.S. Environmental Protection Agency (the “EPA”) and uses a low percentage hydrogen peroxide as its only active ingredient to produce a fog composed mostly of a hydroxyl radical (<strong><sup style="vertical-align:super">.</sup></strong>OH ion), known as ionized Hydrogen Peroxide (iHP™). Represented by the SteraMist® brand of products, iHP™ produces a germ-killing aerosol that works like a visual non-caustic gas.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Our products are designed to service a broad spectrum of commercial structures, including, but not limited to, hospitals and medical facilities, bio-safety labs, pharmaceutical facilities, meat and produce processing facilities, universities and research facilities, vivarium labs, other service industries including cruise ships, office buildings, hotel and motel rooms, schools, restaurants, military barracks, police and fire departments, prisons, and athletic facilities. Our products are also used in single-family homes and multi-unit residences. Additionally, our products have been listed on the EPA’s List N as products that help combat COVID-19 and are actively being used for this purpose.</p>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Certain reclassifications have been made to prior-year comparative financial statements to conform to the current year presentation. These reclassifications had no material effect on previously reported results of operations or financial position.</p>
	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The preparation of the condensed consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the accompanying consolidated financial statements and the accompanying notes. Actual results could differ materially from these estimates. On an ongoing basis, we evaluate our estimates, including those related to accounts receivable, inventory, fair values of financial instruments, intangible assets, useful lives of intangible assets and property and equipment, fair values of stock-based awards, income taxes, and contingent liabilities, among others. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of our assets and liabilities.</p>
CY2024Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-80000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	8000	usd
CY2023Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-73000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-19000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	67290	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	0	usd
CY2024Q2	us-gaap	Pro Forma Weighted Average Shares Outstanding Diluted ProFormaWeightedAverageSharesOutstandingDiluted	22128625	shares
CY2023Q2	us-gaap	Pro Forma Weighted Average Shares Outstanding Diluted ProFormaWeightedAverageSharesOutstandingDiluted	19823955	shares
CY2024Q2	us-gaap	Diluted Earnings Per Share Pro Forma DilutedEarningsPerShareProForma	0.00
CY2023Q2	us-gaap	Diluted Earnings Per Share Pro Forma DilutedEarningsPerShareProForma	-0.00
CY2024Q2	tomz	Effect Of Dilutive Securities Convertible Debt EffectOfDilutiveSecuritiesConvertibleDebt	2080000	shares
CY2024Q2	us-gaap	Basic Earnings Per Share Pro Forma BasicEarningsPerShareProForma	0.00
CY2023Q2	us-gaap	Basic Earnings Per Share Pro Forma BasicEarningsPerShareProForma	-0.00
CY2024Q2	us-gaap	Diluted Earnings Per Share Pro Forma DilutedEarningsPerShareProForma	0.00
CY2023Q2	us-gaap	Diluted Earnings Per Share Pro Forma DilutedEarningsPerShareProForma	-0.00
CY2024Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3532596	shares
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;"> Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash and cash equivalents. We maintain cash balances at financial institutions which exceed the current Federal Deposit Insurance Corporation limit of $250,000 at times during the year.</p>
	tomz	Amortization Of Tenant Improvement Allowance AmortizationOfTenantImprovementAllowance	19597	usd
	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	7531	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
tomz-20240630_cal.xml	Edgar Link	unprocessable
0001654954-24-009807-index-headers.html	Edgar Link	pending
0001654954-24-009807-index.html	Edgar Link	pending
0001654954-24-009807.txt	Edgar Link	pending
0001654954-24-009807-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tomz-20240630.xsd	Edgar Link	pending
tomz_10q.htm	Edgar Link	pending
tomz_10qimg2.jpg	Edgar Link	pending
tomz_ex311.htm	Edgar Link	pending
tomz_ex312.htm	Edgar Link	pending
tomz_ex321.htm	Edgar Link	pending
tomz_ex322.htm	Edgar Link	pending
tomz-20240630_def.xml	Edgar Link	unprocessable
tomz-20240630_lab.xml	Edgar Link	unprocessable
tomz-20240630_pre.xml	Edgar Link	unprocessable
tomz_10q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TOMZ
TOMI Environmental Solutions, Inc. Stock $tomz

2024 Q3 Form 10-Q Financial Statement

#000165495424009807 Filed on August 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TOMZ TOMI Environmental Solutions, Inc. Stock $tomz

2024 Q3 Form 10-Q Financial Statement

#000165495424009807 Filed on August 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TOMZ
TOMI Environmental Solutions, Inc. Stock $tomz